|
|
Many men who have early-stage cancer without any symptoms will have their disease detected before it has had time to spread. This is, by far, the most important argument in favor of prostate cancer screening. When cancer is caught while it is still confined to the prostate, nearly 100% of men survive. When it has spread elsewhere, this number drops significantly.
Both the DRE and PSA test are very easy to perform, require little time, and are not associated with any significant risks.
The percentage of men who die annually of their prostate cancer has declined significantly over the past few years. This is thought by many physicians to be due in part to better screening in addition to improved treatment options.
What Are the Potential Disadvantages of Prostate Cancer Screening?
Many men will have high PSA results, but not actually have prostate cancer. These men then undergo further, ultimately unnecessary, testing to determine if cancer is present or not.
Occasionally men will have low PSA levels and a normal DRE, but actually have prostate cancer. In this situation, men will simply be missed by the screening examinations and go longer without needed treatment.
Some men will have an abnormal PSA or DRE, be correctly diagnosed with prostate cancer, and then appropriately treated, but will actually have disease that would have never spread fast enough to cause them harm. It is a fact that some men have prostate cancer that is never aggressive and will not kill them. Unfortunately, it is currently not possibly to tell who these men are in advance.
So What’s a Guy to Do?
Overall, the majority of primary care physicians and prostate cancer specialists favor the use of prostate cancer screening because they feel that the huge benefit of detecting prostate cancer early in many men outweighs the disadvantages listed above.
Most physicians agree that all men over 50 and men over 45 who have significant risk factors should undergo prostate cancer screening. Some men, however, such as those over the age of 75 and those with significant health problems, likely will not benefit greatly from screening because they are far more likely to pass away from a cause other than prostate cancer.
In order to make an educated decision about whether screening or any other aspect of diagnosis is right for you, you should talk with your physician.
Sources:
Screening for prostate cancer. American College of Physicians. Ann Intern Med 1997; 126:480.
Stem Cells Library , EMR - Resource for EMR, EHR, & PHR; electronic medical records
|
|
Robotic Prostatectomy
